SAVE THE DATE: CROI 2024
As always, the best and most consequential original research will define the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Research that has not been published or presented at a large HIV or SARS-CoV-2 conference prior to CROI will be eligible for inclusion at CROI, the world’s foremost conference of its kind.
This talk considers the role of social and behavioral science at every stage of the clinical trial process from design to enrolment, participation, retention, and outcomes. Based on a review of the literature and three decades’ experience as a social scientist conducting leading HIV and COVID studies, it argues that understanding human behavior and decision-making alongside the context in which these decisions are made are key to effective, efficient, and quality clinical trials.
We are excited to be one of the first conferences to be held in the newly constructed Summit Convention Center in Seattle, Washington.
As always, the best and most consequential original research will define the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Research that has not been published or presented at a large HIV or SARS-CoV-2 conference prior to CROI will be eligible for inclusion at CROI, the world’s foremost conference of its kind.
The purpose of this public workshop is to communicate how FDA’s Generic Drug User Fee Amendments (GDUFA) Science and Research Program outcomes guide and facilitate generic drug development, regulatory assessment, and approval. This workshop will focus on common issues seen in abbreviated new drug applications (ANDAs), link GDUFA science and research on complex products and scientific issues to product-specific guidance development, and pre-ANDA meeting discussions, and examine various areas of innovative science and cutting-edge methodologies behind generic drug development.
SAVE THE DATE
CROI 2022
Denver, CO, USA
The CRS 2021 Virtual Annual Meeting will provide innovative, leading content and topics offering breakthrough delivery science to our attendees.
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2021 will convene March 6 to March 10, 2021.
Long-acting injectables and implants improve the quality of life for patients living with diseases requiring chronic dosing. These life-changing injectables and implants are proven to increase efficacy and enhance patient and dosing compliance.
To meet this growing market need, a large variety of delivery technologies have been developed for all modalities across pharmaceutical products. The knowledge needed to translate from concept to laboratory to actual therapy for these delivery systems is rapidly evolving.
Held every two years, the IAS Conference on HIV Science is a unique forum for scientists, clinicians, public health experts and community leaders to examine the latest research developments in HIV science and explore how to realistically apply and implement that knowledge to address the epidemic.
The Conference On Retroviruses And Opportunistic Infections, organized by the International Antiviral Society-USA will take place from 4th to the 7th March 2019 in Seattle, USA. The conference will cover areas like The World To Share The Latest Studies, Important Developments, And Best Research Methods In The Ongoing Battle Against Hiv/Aids And Related Infectious Diseases Croi Is A Global Model Of Collaborative Science.
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses.
This conference from the Controlled Release Society took place April 18-19, 2017 in Philadelphia at Glaxo Smith Klein Navy Yard
The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses.
Invitation-only Workshop on LA/ER antiretroviral Drugs: Current status and future prospects.